Medivir AB Trials Lipsovir(R) On Cold Sores In Adolescents And The Immunocompromised

STOCKHOLM, Sweden--(BUSINESS WIRE)--Medivir’s pivotal phase III clinical trial with Lipsovir® on cold sores (labial herpes) in the North American adult population is progressing well and 60% of the patients have now been treated.